Grown Rogue International (GRUSF) EBITDA (2009 - 2026)
Grown Rogue International (GRUSF) recorded quarterly EBITDA of -$2.2 million in Q1 2026, up 100.0% quarter-over-quarter from -$5339.6 billion in Q4 2025, and down 394.84% on a YoY basis from $750702.0 in Q1 2025.
Grown Rogue International (GRUSF) EBITDA (2009 - 2026) Analysis & Trends
Grown Rogue International's EBITDA history runs 17 years deep, the most recent figure standing at -$2.2 million for Q1 2026.
- In Q1 2026, EBITDA fell 394.84% year-over-year to -$2.2 million; the TTM figure through Mar 2026 stood at -$2501.7 billion (down 121.3% YoY), while the FY2025 annual figure was $3.2 million, up 120.22% from the prior year.
- EBITDA was -$2.2 million for Q1 2026 at Grown Rogue International, up from -$5339.6 billion in the prior quarter.
- In the past five years, EBITDA ranged from a high of $12415.1 billion in Q4 2024 to a low of -$5339.6 billion in Q4 2025.
- Historically, EBITDA has averaged $616.4 billion across 5 years, with a median of $410091.0 in 2023.
- The sharpest annual moves came in 2024 and 2026: EBITDA surged 1829699708.67% in 2024, then sank 394.84% in 2026.
- A 5-year view of EBITDA shows it stood at $141783.0 in 2022, then jumped by 378.57% to $678533.0 in 2023, then soared by 1829699708.67% to $12415.1 billion in 2024, then plunged by 143.01% to -$5339.6 billion in 2025, then soared by 100.0% to -$2.2 million in 2026.
- The last three EBITDA figures came in at -$2.2 million (Q1 2026), -$5339.6 billion (Q4 2025), and $2837.9 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -681,231.97 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 185.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -67.29 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 81.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -98.81 Mn |
| 10 | Grown Rogue International | - | - | 3.96 Mn | -2.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.21 Mn |
| Dec 31, 2025 | -5,339.57 Bn |
| Sep 30, 2025 | 2,837.89 Bn |
| Jun 30, 2025 | 1.41 Mn |
| Mar 31, 2025 | 750,702.00 |
| Dec 31, 2024 | 12,415.12 Bn |
| Sep 30, 2024 | -667.74 Bn |
| Jun 30, 2024 | -5.54 Mn |
| Mar 31, 2024 | -4.17 Mn |
| Dec 31, 2023 | 678,533.00 |
| Oct 31, 2023 | -1.26 Mn |
| Jul 31, 2023 | 759,806.00 |
| Apr 30, 2023 | 410,091.00 |
| Jan 31, 2023 | 591,115.00 |
| Jan 31, 2022 | 141,783.00 |
| Oct 31, 2021 | 1.11 Mn |
| Jul 31, 2021 | 228,593.00 |
| Apr 30, 2021 | -1.44 Mn |
| Jan 31, 2021 | -1.07 Mn |
| Oct 31, 2020 | -146,373.00 |